Observations placeholder
Humira
Identifier
019108
Type of Spiritual Experience
Number of hallucinations: 165
Background
A description of the experience
Adalimumab, trade names Humira and Exemptia are TNF inhibiting anti-inflammatory medication. Adalimumab has been approved in the United States for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, moderate to severe chronic psoriasis and juvenile idiopathic arthritis.
"Because TNFα is part of the immune system that protects the body from infection, treatment with adalimumab may increase the risk of infections".
On Dec, 26, 2016 358,739 people reported to have side effects when taking Humira.
Among them, 165 people (0.05%) have Hallucination
Time on Humira when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 39.29% | 39.29% | 0.00% | 10.71% | 10.71% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Humira :
| Female | Male | |
| Hallucination | 82.93% | 17.07% |
Age of people who have Hallucination when taking Humira :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 0.00% | 1.52% | 19.70% | 7.58% | 3.03% | 10.61% | 57.58% |
On Nov, 24, 2015: 136,065 people reported to have side effects when taking Humira. Among them, 1,149 people (0.84%) have Death.
Time on Humira when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 19.67% | 24.80% | 13.93% | 17.21% | 19.47% | 4.71% | 0.20% |
Gender of people who have Death when taking Humira :
| Female | Male | |
| Death | 56.69% | 43.31% |
Age of people who have Death when taking Humira :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Death | 0.00% | 0.00% | 0.13% | 1.65% | 4.06% | 13.94% | 18.50% | 61.72% |
Top conditions involved for these people :
- Rheumatoid arthritis (645 people, 56.14%)
- Crohn's disease (178 people, 15.49%)
- Psoriasis (120 people, 10.44%)
- Pain (68 people, 5.92%)
- Hypertension (60 people, 5.22%)